About one in six working adults in the U.S. battle a substance use disorder, and nearly 10% of U.S. employees have a cannabis or stimulant use disorder.
Recognizing this, Carrum Health has expanded its substance use disorder treatment program to include cannabis, sedatives and stimulants, the company announced on Wednesday. It previously only covered opioids and alcohol. The company offers a value-based specialty care Centers of Excellence solution for self-insured employers.
Carrum’s support for cannabis, sedative and stimulant use is based on its framework for opioid and alcohol use. When a member seeks support, they…
